Skip to content

Clinical trials

Phase 3 Leukemia, Myeloid, Acute trials in Czechia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myeloid, Acute Phase: Phase 3 Country / region: Czechia Clear all

34 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20103
20121
20132
20142
20151
20162
20175
20184
20202
20212
20222
20241
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed21
Terminated5
Recruiting4
Active, not recruiting3
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie4
European Organisation for Research and Treatment of Cancer - EORTC4
Daiichi Sankyo3
Astex Pharmaceuticals, Inc.2
Celgene2
Novartis Pharmaceuticals2
Pfizer2
Boehringer Ingelheim1
Eisai Inc.1
Gilead Sciences1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myeloid, Acute34
Leukemia11
Myelodysplastic Syndromes5
Leukemia, Myelomonocytic, Chronic4
Recurrence4
Neoplasms3
Blast Crisis2
Burkitt Lymphoma2
Dendritic Cell Sarcoma, Interdigitating2
Fever2

Trials

Showing 1 to 25 of 34. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.